242 related articles for article (PubMed ID: 33179113)
1. Activation of activin/Smad2 and 3 signaling pathway and the potential involvement of endothelial‑mesenchymal transition in the valvular damage due to rheumatic heart disease.
Xian S; Chen A; Wu X; Lu C; Wu Y; Huang F; Zeng Z
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179113
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of miR‑155‑5p attenuates the valvular damage induced by rheumatic heart disease.
Chen A; Wen J; Lu C; Lin B; Xian S; Huang F; Wu Y; Zeng Z
Int J Mol Med; 2020 Feb; 45(2):429-440. PubMed ID: 31894293
[TBL] [Abstract][Full Text] [Related]
3. Interference with the expression of S1PR1 or STAT3 attenuates valvular damage due to rheumatic heart disease.
Xian S; Chen A; Wu Y; Wen H; Lu C; Huang F; Zeng Z
Int J Mol Med; 2021 Sep; 48(3):. PubMed ID: 34296288
[TBL] [Abstract][Full Text] [Related]
4. Potential involvement of S1PR1/STAT3 signaling pathway in cardiac valve damage due to rheumatic heart disease.
Wu XD; Zeng ZY; Gong DP; Wen JL; Huang F
Biotech Histochem; 2019 Aug; 94(6):398-403. PubMed ID: 30712389
[TBL] [Abstract][Full Text] [Related]
5. The Role of Interleukin-13 in Patients with Rheumatic Valvular Fibrosis: A Clinical and Histological Study.
Liu Q; Qiao WH; Li FF; Deng P; Hu ZW
J Heart Valve Dis; 2015 Jul; 24(4):496-501. PubMed ID: 26897823
[TBL] [Abstract][Full Text] [Related]
6. Changes in the expression of Th17 cell-associated cytokines in the development of rheumatic heart disease.
Wen Y; Zeng Z; Gui C; Li L; Li W
Cardiovasc Pathol; 2015; 24(6):382-7. PubMed ID: 26318798
[TBL] [Abstract][Full Text] [Related]
7. Pathology and pathogenesis of rheumatic heart disease.
Chopra P; Gulwani H
Indian J Pathol Microbiol; 2007 Oct; 50(4):685-97. PubMed ID: 18306530
[TBL] [Abstract][Full Text] [Related]
8. Activin receptor-like kinase 7 mediates high glucose-induced H9c2 cardiomyoblast apoptosis through activation of Smad2/3.
Liu L; Ding WY; Zhao J; Wang ZH; Zhong M; Zhang W; Chen YG; Zhang Y; Li L; Tang MX
Int J Biochem Cell Biol; 2013 Sep; 45(9):2027-35. PubMed ID: 23830891
[TBL] [Abstract][Full Text] [Related]
9. CD4
Zhao Z; He D; Ling F; Chu T; Huang D; Wu H; Ge J
Exp Mol Pathol; 2020 Jun; 114():104402. PubMed ID: 32061942
[TBL] [Abstract][Full Text] [Related]
10. Effects of activin A and its downstream ERK1/2 in oxygen and glucose deprivation after isoflurane-induced postconditioning.
Wang Q; Yin J; Wang S; Cui D; Lin H; Ge M; Dai Z; Xie L; Si J; Ma K; Li L; Zhao L
Biomed Pharmacother; 2016 Dec; 84():535-543. PubMed ID: 27693962
[TBL] [Abstract][Full Text] [Related]
11. Anti-renal fibrosis effect of asperulosidic acid via TGF-β1/smad2/smad3 and NF-κB signaling pathways in a rat model of unilateral ureteral obstruction.
Xianyuan L; Wei Z; Yaqian D; Dan Z; Xueli T; Zhanglu D; Guanyi L; Lan T; Menghua L
Phytomedicine; 2019 Feb; 53():274-285. PubMed ID: 30668407
[TBL] [Abstract][Full Text] [Related]
12. MFGE8 is down-regulated in cardiac fibrosis and attenuates endothelial-mesenchymal transition through Smad2/3-Snail signalling pathway.
Wang B; Ge Z; Wu Y; Zha Y; Zhang X; Yan Y; Xie Y
J Cell Mol Med; 2020 Nov; 24(21):12799-12812. PubMed ID: 32945126
[TBL] [Abstract][Full Text] [Related]
13. Pluripotency gene expression and growth control in cultures of peripheral blood monocytes during their conversion into programmable cells of monocytic origin (PCMO): evidence for a regulatory role of autocrine activin and TGF-β.
Ungefroren H; Hyder A; Hinz H; Groth S; Lange H; El-Sayed KM; Ehnert S; Nüssler AK; Fändrich F; Gieseler F
PLoS One; 2015; 10(2):e0118097. PubMed ID: 25707005
[TBL] [Abstract][Full Text] [Related]
14. Expression of SMADs in orthotopic human endometrium, ovarian endometriosis, and endometriotic lesions in a murine model.
Kadota Y; Kato T; Kasai K; Kawakita T; Murayama M; Shinya A; Sasada H; Katayama S; Nii M; Yamamoto S; Noguchi H; Tamura K; Aoki H; Taniguchi M; Nakagawa T; Kaji T; Nishimura M; Kinouchi R; Yoshida K; Iwasa T
Endocr J; 2024 Apr; 71(4):395-401. PubMed ID: 38417880
[TBL] [Abstract][Full Text] [Related]
15. Activin Signals through SMAD2/3 to Increase Photoreceptor Precursor Yield during Embryonic Stem Cell Differentiation.
Lu AQ; Popova EY; Barnstable CJ
Stem Cell Reports; 2017 Sep; 9(3):838-852. PubMed ID: 28781074
[TBL] [Abstract][Full Text] [Related]
16. High-Mobility Group Box 1 Mediates Epithelial-to-Mesenchymal Transition in Pulmonary Fibrosis Involving Transforming Growth Factor-β1/Smad2/3 Signaling.
Li LC; Li DL; Xu L; Mo XT; Cui WH; Zhao P; Zhou WC; Gao J; Li J
J Pharmacol Exp Ther; 2015 Sep; 354(3):302-9. PubMed ID: 26126535
[TBL] [Abstract][Full Text] [Related]
17. Differential Role of Smad2 and Smad3 in the Acquisition of an Endovascular Trophoblast-Like Phenotype and Preeclampsia.
Brkić J; Dunk C; Shan Y; O'Brien JA; Lye P; Qayyum S; Yang P; Matthews SG; Lye SJ; Peng C
Front Endocrinol (Lausanne); 2020; 11():436. PubMed ID: 32733385
[TBL] [Abstract][Full Text] [Related]
18. Cloning of Smad2, Smad3, Smad4, and Smad7 from the goldfish pituitary and evidence for their involvement in activin regulation of goldfish FSHbeta promoter activity.
Lau MT; Ge W
Gen Comp Endocrinol; 2005 Mar; 141(1):22-38. PubMed ID: 15707600
[TBL] [Abstract][Full Text] [Related]
19. ALK4-SMAD2/3-SMAD4 signaling mediates the activin A-induced suppression of PTX3 in human granulosa-lutein cells.
Liu C; Chang HM; Yi Y; Fang Y; Zhao F; Leung PCK; Yang X
Mol Cell Endocrinol; 2019 Aug; 493():110485. PubMed ID: 31185247
[TBL] [Abstract][Full Text] [Related]
20. Repeat exposure to group A streptococcal M protein exacerbates cardiac damage in a rat model of rheumatic heart disease.
Gorton D; Sikder S; Williams NL; Chilton L; Rush CM; Govan BL; Cunningham MW; Ketheesan N
Autoimmunity; 2016 Dec; 49(8):563-570. PubMed ID: 27562362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
